Public SEC Form D records
Biotech Series B Form D filings - September 2026
This page lists the 6 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series B stage in September 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 6
- Issuers
- 6
- Combined disclosed
- $139.4M
Directory links
Filing records
6 crawlable filing links in this facet.
- GT Biopharma, Inc.September 29, 2026 / Reg D 506(b) / CA$39.0M
- Pictura Bio US, Inc.September 28, 2026 / Reg D 506(b)$17.5M
- Xact Bio, Inc.September 28, 2026 / Reg D 506(b) / MA$18.0M
- Avery Therapeutics, Inc.September 21, 2026 / Reg D 506(b) / AZ$15.4M
- CERENOME, INC.September 18, 2026 / Reg D 506(b) / TX$20.0M
- Cloverleaf Bio, Inc.September 9, 2026 / Reg D 506(b) / CT$29.6M